Harbour Investments’s Annovis Bio ANVS Stock Holding History

Harbour Investments’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6	Closed	–	–	2652
2021 Q3	$0	Buy	+6	New	+$345	﹤0.01%	3712

Other funds holding ANVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

WFAG

Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Harbour Investments's ANVS Position: Q4 2021 in Review

Harbour Investments sold out of Annovis Bio (ANVS) in Q4 2021, closing a stake of 6 shares.

Harbour Investments first reported a position in ANVS in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 32 funds tracked by Wall St. Rank hold ANVS as of Q4 2021.

Harbour Investments reported no remaining Annovis Bio position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 6 Annovis Bio shares in Q4 2021.
Harbour Investments first reported a position in Annovis Bio in Q3 2021 and held it in 1 quarter.
Harbour Investments's Annovis Bio position peaked at $0 in Q3 2021.
32 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.